Nigeria is in the process of obtaining the US FDA-approved coronavirus treatment drug, remdesivir, for use on patients in the country, according to Chikwe Ihekweazu, the director-general of the Nigeria Centre for Disease Control (NCDC).
The US Food and Drug Administration (FDA) authorised emergen
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```